The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Biogen Idec to Present at the Deutsche Bank 36th Annual Healthcare Conference

Wednesday, April 27, 2011

Biogen Idec to Present at the Deutsche Bank 36th Annual Healthcare Conference12:26 EDT Wednesday, April 27, 2011 WESTON, Mass. (Business Wire) -- Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Deutsche Bank 36th Annual Healthcare Conference will be webcast live on Tuesday, May 3, 2011 at 8:00 a.m. ET. To access the live webcast, please visit Biogen Idec's Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation. About Biogen Idec Biogen Idec uses cutting edge science to discover, develop, manufacture and market therapeutic products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies and the company generates more than $4 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com. Biogen IdecKaren Jewell, 781-464-2442Investor Relations